Bg pattern

IMUKIN 100 micrograms INJECTABLE SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

4.6 (76)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate

Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use IMUKIN 100 micrograms INJECTABLE SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

IMUKIN 100 micrograms solution for injection

Recombinant human interferon gamma-1b

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is IMUKIN and what is it used for
  2. What you need to know before you use IMUKIN
  3. How to use IMUKIN
  4. Possible side effects
  5. Storing IMUKIN
  6. Contents of the pack and other information

1. What is IMUKIN and what is it used for

IMUKIN contains the active substance recombinant human interferon gamma-1b. Interferons are also known as immunomodulators. These are small proteins capable of stimulating the body's defense mechanisms. They protect against microorganisms (such as bacteria, viruses, and fungi) that can cause diseases.

IMUKIN is used in patients with chronic granulomatous disease (CGD). CGD is a deficiency in the metabolism of neutrophils, a type of white blood cell that normally eradicates bacteria or fungi that invade the body. The deficient alteration of CGD makes neutrophils less capable of preventing infections.

IMUKIN is used to reduce the frequency of severe infections that can occur with this disease.

IMUKIN is also used in patients with severe malignant osteopetrosis. This is a hereditary defect in bone cells that produces excessive and abnormal bone growth. It also affects the bone marrow and the blood cells that are normally formed in it. Consequently, patients with osteopetrosis also have a risk of severe infections.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use IMUKIN

Do not use IMUKIN

  • if you are allergic to interferon gamma or other related interferons or to some of the other ingredients of this medicine (listed in section 6).

Ask your doctor or pharmacist if you are not sure if you are allergic to interferons.

Warnings and precautions

Consult your doctor or pharmacist before starting treatment with IMUKIN.

Be careful with IMUKIN

  • if you have heart disease, as doses higher than the usual doses may worsen your heart disease (see section 3 for dosage)
  • if you have seizure disorders and/or alterations in central nervous system function
  • if your liver does not function normally (liver failure)
  • if your kidney does not function normally (kidney failure)
  • if your bone marrow does not produce blood cells in normal quantities (myelosuppression)
  • if you are allergic to latex, as the rubber stopper of the glass vial contains natural rubber (a latex derivative) that can cause allergic reactions.

Consult your doctor if any of the above circumstances apply to you now or have applied to you in the past.

You should avoid using IMUKIN with other medicines that contain proteins. You should also avoid using IMUKIN at the same time as you are given a vaccine. Consult your doctor if you have any doubts about this.

You should continue to undergo the tests used in the treatment of CGD and severe malignant osteopetrosis. You should be carefully monitored, with your blood cell count, urine, and liver and kidney function being checked both before and during treatment.

High levels of interferon gamma-1b in the body can damage fertility in men and women.

Other medicines and IMUKIN

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

You may need antibiotics to treat infections that still occur while you are using IMUKIN for the treatment of CGD. It has not been shown that IMUKIN affects the efficacy of antibiotics or corticosteroids, medicines commonly used in patients with CGD and severe malignant osteopetrosis.

Medicines that affect the liver or kidneys may affect the elimination of IMUKIN from the body. IMUKIN may prolong the activity of other medicines that are broken down and eliminated from the body through the liver.

If you use IMUKIN with medicines or vaccines that have effects on the heart, blood, bone marrow, nervous system, or immune system, the risk of side effects may increase.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Based on available information, the effects on fertility are not known, but they cannot be excluded. IMUKIN should not be used during pregnancy unless your doctor considers it essential. Breastfeeding is not recommended during treatment with IMUKIN. Consult your doctor or pharmacist before using any medicine.

Driving and using machines

IMUKIN may cause fatigue, seizures (convulsions), confusion, disorientation, or distorted or imaginary sensations (hallucinations). These side effects can reduce your reaction ability, which may have a negative effect on your ability to drive and use machines. Do not drive or use machines if you notice that your reaction ability is reduced.

IMUKIN contains sodium

This medicine contains less than 1 mmol of sodium (23 mg) per 0.5 ml vial, so it is considered essentially "sodium-free".

This may be important for people with high blood pressure and others who want to maintain a low-sodium diet.

3. How to use IMUKIN

Follow the instructions for administration of this medicine exactly as indicated by your doctor or pharmacist. If you are in doubt, consult your doctor or pharmacist again.

IMUKIN should be administered by subcutaneous injection. IMUKIN can be administered by a doctor or a nurse and also by you or a family member, provided they have been previously instructed by a doctor or a nurse.

The recommended dose of IMUKIN for the treatment of patients with CGD or severe malignant osteopetrosis is 50 micrograms/m2 in those patients whose body surface area is greater than 0.5 m2 and 1.5 micrograms/kg for patients whose body surface area is less than or equal to 0.5 m2.

Your doctor will decide how much IMUKIN you need to use for the treatment of CGD or severe malignant osteopetrosis.

You should inject (or should be injected) under your skin the exact amount of IMUKIN that your doctor has indicated you need. You should administer the injections 3 times a week (e.g., Monday, Wednesday, and Friday), preferably at night. The recommended injection sites are the upper arm or the upper thigh.

  • Before administering the injection, always check the amount of IMUKIN solution.
  • Do not use IMUKIN if you can see small particles or discoloration of the solution.
  • Do not mix IMUKIN with other medicines.
  • Do not shake the IMUKIN vials vigorously.

If you use more IMUKIN than you should

Consult your doctor immediately if you have administered more IMUKIN than your doctor has indicated or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken. It is recommended to take the package and leaflet to the healthcare professional.

The symptoms after administration of too much IMUKIN may include:

  • central nervous system side effects such as difficulty thinking, difficulty walking, and dizziness
  • if you have heart disease, it may worsen for a short period
  • blood disorders may occur during treatment with IMUKIN, including:
  • temporary changes in the amount of some blood cells
  • increased levels of certain substances (liver enzymes and triglycerides) in the blood.

Your doctor may detect these changes with a blood test.

These symptoms disappear with a decrease in the dose or interruption of treatment with IMUKIN.

If you forget to use IMUKIN

Do not take a double dose to make up for forgotten doses.

Administer your injections according to the schedule recommended by your doctor. You can still administer it on the same day or the next day. Consult your doctor if you think you have been without administering a dose for too long.

If you stop treatment with IMUKIN

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Tell your doctor if you stop treatment with IMUKIN.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. The risk of side effects depends on the dose and administration schedule indicated by your doctor.

The most common side effects are flu-like symptoms such as fever, headache, chills, and fatigue.

These may decrease in severity over time as treatment continues. Some of these symptoms can be minimized by administering IMUKIN just before bedtime. A medicine like paracetamol can be used to reduce some of these effects.

Some patients who use IMUKIN may experienceshort-term skin problems, such asa temporary skin rash, spotted rashes, sudden appearance of blisters on the skin, and redness of the skin at the injection site.

However, they have rarely been severe enough to interrupt treatment with IMUKIN.

The following side effects are grouped by frequency:

Very common side effects (may affect more than 1 in 10 people) are:

  • fever
  • headache
  • chills
  • pain at the injection site
  • vomiting
  • nausea (feeling sick)
  • diarrhea
  • fatigue
  • high liver enzyme levels
  • skin rash

Common side effects (may affect up to 1 in 10 people) are:

  • muscle pain
  • joint pain
  • back pain
  • stomach pain
  • depression

Frequency not known (cannot be estimated from the available data):

  • decrease in white blood cells (neutropenia)
  • decrease in blood platelets (thrombocytopenia) that may be associated with the appearance of bruises and tendency to bleed
  • proteins in the urine

Side effects have also been observed in patients with diseases other than CGD and severe malignant osteopetrosis. These side effects have not been observed in clinical trials related to CGD or severe malignant osteopetrosis.

The following side effects have been reported in clinical trials with patients who had disorders/diseases other than CGD or severe malignant osteopetrosis. The usual doses used in these studies were higher than those recommended for the treatment of CGD and severe malignant osteopetrosis. For this reason, their frequency of occurrence cannot be precisely determined.

Frequency not known (cannot be estimated from the available data):

  • low sodium levels in the blood, which can cause fatigue and confusion, muscle contractions, seizures, or coma (hyponatremia)
  • high levels of a sugar called glucose (hyperglycemia)
  • high levels of fatty acids called triglycerides (hypertriglyceridemia) in the blood

The following nervous system disorders have been observed:

  • confusion
  • disorientation
  • effects on walking ability, such as parkinsonian gait
  • tremors
  • seizures
  • distorted or imaginary sensations (hallucinations)

The following heart disorders have also been observed:

  • extra and irregular heartbeats
  • changes in heart rhythm, such as increased or decreased heart rate
  • heart problems that can cause difficulty breathing or swelling of the ankle (heart failure)
  • heart attack

The following blood system disorders have also been reported:

  • low blood pressure
  • fainting
  • temporary mild stroke (transient ischemic attack)
  • blood clots or blockage of a lung artery (deep vein thrombosis and pulmonary embolism); symptoms may include difficulty breathing

The following respiratory disorders have been observed:

  • rapid breathing
  • chest tightness (bronchospasm or interstitial lung disease)
  • bleeding in the digestive system
  • inflammation of the pancreas, which can cause death
  • liver damage that affects its function (liver failure)
  • kidney damage that affects its function but can be effectively treated (reversible kidney failure)
  • chest pain
  • worsening of a skin disease called dermatomyositis (presenting as a skin rash accompanied by muscle weakness)
  • development of a long-term disease called systemic lupus erythematosus (the patient's immune system attacks several parts of the body)
  • autoimmune reaction (auto-antibody response)

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Monitoring System: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storing IMUKIN

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and vial after "EXP". The expiry date is the last day of the month stated.

Store in a refrigerator (between 2°C and 8°C). Do not freeze.

The IMUKIN solution for injection vials should be used once only. IMUKIN does not contain preservatives.

Once opened, the contents of a vial should be used immediately. Discard the leftover solution.

Do not use this medicine if you notice the presence of particles or discoloration before use.

Medicines should not be disposed of via wastewater or household waste. Dispose of the packaging and any unused medicine in the SIGRE collection point at the pharmacy. If you are in doubt, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.

6. Contents of the pack and other information

Composition of IMUKIN

  • The active substance is recombinant human interferon gamma-1b. Each vial (0.5 ml) contains 100 micrograms (2 x 10^6 IU) of recombinant human interferon gamma-1b. It is produced by the bacterium E. colimodified by genetic engineering.
  • The other ingredients are D-mannitol, disodium succinate hexahydrate, polysorbate 20, succinic acid, and water for injections.

The rubber stopper of the glass vial contains natural rubber (a latex derivative).

Appearance and packaging

IMUKIN is a clear and colorless solution for injection. It is available in 4 ml vials containing 0.5 ml of solution.

Package sizes: 1, 3, 5, 6, and 12 vials in a cardboard box. Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder

Clinigen Healthcare B.V.

Schiphol Boulevard 359

WTC Schiphol Airport, D Tower 11th floor

1118BJ Schiphol

Netherlands

Manufacturer

Almac Pharma Services (Ireland) Limited

Finnabair Industrial Estate

Dundalk,

Co. Louth

A91 P9KD

Ireland

or

Almac Pharma Services Limited

Seagoe Industrial Estate

BT63 5UA Craigavon

Northern Ireland, United Kingdom

This medicine is authorized in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:

Austria, France, Germany, Italy, Norway, Spain

IMUKIN

Netherlands

IMMUKINE

United Kingdom (Northern Ireland)

IMMUKIN

Date of last revision of this leaflet: November 2022

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for IMUKIN 100 micrograms INJECTABLE SOLUTION

Discuss questions about IMUKIN 100 micrograms INJECTABLE SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (100)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

5.0 (197)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

5.0 (97)
Doctor

Jorge Correa Bellido

General medicine 7 years exp.

Dr. Jorge Correa Bellido is a Spanish physician who offers online consultations in Spanish and English. He graduated from the University of La Laguna and has a solid background in clinical practice and international research.

Throughout his career, he has participated in various medical and academic projects, including a research fellowship in Spain, where he contributed to evidence-based studies in the field of family medicine. This experience allowed him to broaden his global perspective on healthcare and comprehensive patient care.

Dr. Correa Bellido has worked with several healthcare providers in Spain, focusing particularly on patient-centered care and public health initiatives aimed at communities with limited access to healthcare services.

In addition, he actively participates in international medical conferences and workshops, which allows him to stay up to date with the latest medical advances and collaborate with healthcare professionals from different countries.

Dr. Correa Bellido provides comprehensive care for a wide variety of medical conditions, including:

  • respiratory infections
  • gastrointestinal disorders
  • cardiovascular problems
  • endocrine and metabolic diseases
  • musculoskeletal and dermatological conditions
  • as well as mental health conditions such as anxiety and depression.

He also treats infectious and allergic diseases, general health concerns, and provides guidance on prevention and healthy lifestyle habits.

His services include virtual consultations, diagnosis and management of acute and chronic diseases, prescription renewals, and personalized medical advice.

With a patient-centered approach and a strong commitment to continuous learning, Dr. Correa Bellido provides accessible and high-quality healthcare to patients both in Spain and around the world.

4.6 (76)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate

Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

0.0 (10)
Doctor

Lizaveta Trafimchuk Takhvaniuk

Dermatology 10 years exp.

Dr. Lizaveta Trafimchuk Takhvaniuk graduated in Medicine and subsequently specialized in Dermatology and Venereology. She has more than 10 years of clinical experience and is licensed to practice in Spain, where she focuses on the comprehensive diagnosis and treatment of dermatological conditions.

Throughout her education and professional career, Dr. Trafimchuk has gained extensive experience in managing diseases of the skin, hair, and nails, as well as in the diagnosis, treatment, and prevention of sexually transmitted infections (STIs). Her clinical approach is based on evidence-based medicine, combined with personalized care tailored to each patient’s needs.

In her daily practice, she treats a wide range of dermatological conditions, including chronic inflammatory dermatoses such as acne, rosacea, atopic dermatitis, psoriasis, and eczema. She also has experience in treating pigmentation disorders, including melasma, post-inflammatory hyperpigmentation, and dyschromia.

She has developed a particular interest in trichology, treating various types of alopecia, chronic hair loss, and scalp disorders. In addition, she has experience in managing infectious dermatoses of fungal, viral, and bacterial origin, as well as in evaluating benign and suspicious skin lesions, with referral to specialized care when necessary.

With a strong interest in a comprehensive approach to skin health, she also treats scars, post-procedural skin changes, and conditions related to hormonal factors and aging, including those associated with pregnancy, menopause, and age-related skin changes.

Thanks to her experience and continuous professional development, Dr. Trafimchuk provides high-quality medical care that is professional, confidential, and aligned with modern dermatology standards.

5.0 (1225)
Doctor

Andrei Popov

General medicine 7 years exp.

Dr. Andrei Popov is a family physician with specialized training in the management of chronic pain. He provides video consultations for adults in Spain and across Europe: whether you have been living with pain for months that no one has been able to properly explain, or you need to resolve a health issue without waiting weeks for an appointment.

His approach is clear: to listen, organize your case, and provide you with a practical roadmap based on evidence-based medicine and adapted to your medical history and personal needs.

Pain: how he can help

  • Chronic pain (more than 3 months
  • Migraine and recurrent or high-intensity headaches
  •  Neck, lower back, back and joint pain
  •  Post-traumatic pain after injuries or surgeries
  •  Pain of neurological origin: neuralgia, neuropathic pain, fibromyalgia

General medicine

  • Frequent respiratory infections (cold, flu, persistent cough)
  • Hypertension, diabetes and metabolic disorders
  • Review of laboratory tests and MRI/CT reports (explained in clear language)
  • Preventive medicine and health monitoring
  • Second opinions and treatment adjustments (when clinically appropriate)

What the consultation is like
 Each session lasts up to 30 minutes. We review symptoms, medical history, medications and any tests you provide, and you finish the consultation with a clear treatment plan, defined next steps, and criteria to understand when follow-up may be needed. If warning signs are detected, he will clearly advise whether you need in-person care or urgent medical attention.

0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
0.0 (11)
Doctor

Rita Isabel Calero Garcia

General medicine 2 years exp.

Dr. Rita Isabel Calero Garcia is a physician with extensive experience in emergency medical care, general medicine, and healthcare assistance in various clinical and out-of-hospital settings.

She currently works as a physician at the Canary Islands Emergency Service (Servicio de Urgencias Canario – SUC), where she is responsible for the assessment and care of patients in medical emergency situations, performing the initial diagnosis, patient stabilization, and coordination with hospital services when necessary.

She has also developed her professional activity within the Primary Care Management Service, providing consultations in general medicine. In this setting she is responsible for patient follow-up, management of acute and chronic conditions, as well as health promotion and disease prevention.

She has also worked as a physician in a mobile ICU unit, providing medical assistance in out-of-hospital emergencies, treating critical patients and participating in medicalized patient transport.

In addition, she has collaborated with the Red Cross, participating in healthcare support units, providing medical assistance at events and supporting emergency interventions.

Furthermore, she has provided medical services in the private sector with Salvaser, conducting clinical assessments of patients and providing healthcare services within private medical services.

Get IMUKIN 100 micrograms INJECTABLE SOLUTION Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

Is a prescription required for IMUKIN 100 micrograms INJECTABLE SOLUTION?

IMUKIN 100 micrograms INJECTABLE SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

What is the active substance in IMUKIN 100 micrograms INJECTABLE SOLUTION?

The active ingredient in IMUKIN 100 micrograms INJECTABLE SOLUTION is interferon gamma. This information helps identify medicines with the same composition but different brand names.

Who manufactures IMUKIN 100 micrograms INJECTABLE SOLUTION?

IMUKIN 100 micrograms INJECTABLE SOLUTION is manufactured by Clinigen Healthcare B.V.. Pharmacy brands and packaging may differ depending on the distributor.

Which doctors can assess the use of IMUKIN 100 micrograms INJECTABLE SOLUTION online?

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether IMUKIN 100 micrograms INJECTABLE SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

How to buy IMUKIN 100 micrograms INJECTABLE SOLUTION in Spain?

Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.

You can buy IMUKIN 100 micrograms INJECTABLE SOLUTION in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.

To obtain a prescription, you can use Oladoctor:

What are the alternatives to IMUKIN 100 micrograms INJECTABLE SOLUTION?

Other medicines with the same active substance (interferon gamma) include AVONEX 30 micrograms/0.5 ml SOLUTION FOR INJECTION IN PRE-FILLED PEN, AVONEX 30 micrograms/0.5 ml INJECTABLE SOLUTION, BESREMI 250 micrograms/0.5 ml solution for injection in a prefilled pen. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media